STATE BILLKY SB 56ENGROSSED

AN ACT relating to utilization controls for nonopioid analgesics in the Medicaid program.

Commonwealth of Kentucky

Create a new section of KRS Chapter 205 to prohibit the Department for Medicaid Services, any Medicaid managed care organization contracted by the department, and the Medicaid state pharmacy benefit manager from denying coverage for a nonopioid analgesic in favor of opioid analgesic or establishing more restrictive or more extensive utilization controls for nonopioid analgesics than the least restrictive or extensive utilization controls for any opioid or narcotic analgesic; require the Cabinet for Health and Family Services or the Department for Medicaid to seek federal approval if it is determined that such approval is necessary; provide authorization from the General Assembly to make changes to the Medicaid program as required under KRS 205.5372(1).

Status
Engrossed
Passed its first chamber
Status date
Mar 2, 2026
255 days ago
Current chamber
Senate
Session
2026 Regular Session
KY SB 56 · EngrossedMar 2

Follow the legislation that affects what you sell.

Get started free

Free account · 30-second setup · No credit card

What it means for vendors

Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.

Bill details

Last action
passed over and retained for concurrence in House Floor Amendment (1) and Floor Amendment (2-title) · Apr 15, 2026
Pending committee
Rules

Sponsors

GNGerald NealSenator · Democrat · SD-033Primary sponsor
GEGreg ElkinsSenator · Republican · SD-028
SMScott MadonSenator · Republican · SD-029
AMAmanda Mays BledsoeSenator · Republican · SD-012
RTReginald ThomasSenator · Democrat · SD-013

Bill history

Newest first.

Apr 15, 2026passed over and retained for concurrence in House Floor Amendment (1) and Floor Amendment (2-title)Senate
Apr 15, 2026posted for passage for concurrence in House Floor Amendments (1) and (2-title)Senate
Apr 15, 2026to Rules (S)Senate
Apr 15, 2026received in SenateSenate
Apr 15, 20263rd reading, passed 82-9 with Floor Amendment (1) and Floor Amendment (2-title)House
Apr 14, 2026floor amendments (3) and (4-title) filedHouse
Mar 26, 2026floor amendments (1) and (2-title) filedHouse
Mar 24, 2026posted for passage in the Regular Orders of the Day for Wednesday, March 25 2026House
Show 14 earlier actions
Mar 20, 20262nd reading, to RulesHouse
Mar 19, 2026reported favorably, 1st reading, to CalendarHouse
Mar 11, 2026to Health Services (H)House
Mar 2, 2026to Committee on Committees (H)House
Mar 2, 2026received in HouseHouse
Feb 27, 20263rd reading, passed 35-0Senate
Feb 26, 2026passed over and retained in the Orders of the DaySenate
Feb 25, 2026passed over and retained in the Orders of the DaySenate
Feb 23, 2026posted for passage in the Regular Orders of the Day for Wednesday, February 25 2026Senate
Feb 12, 20262nd reading, to RulesSenate
Feb 11, 2026reported favorably, 1st reading, to CalendarSenate
Feb 9, 2026to Health Services (S)Senate
Jan 9, 2026to Committee on Committees (S)Senate
Jan 9, 2026introduced in SenateSenate

Recorded votes

Senate: Third Reading RSN# 3865Feb 27, 2026 · Senate · 35 yea · 0 nayPassed
House: Veto Override RCS# 494Apr 15, 2026 · House · 79 yea · 0 nayPassed
House: Veto Override RCS# 495Apr 15, 2026 · House · 82 yea · 9 nayPassed

Subjects

  • Drugs and Medicines
  • Medicaid
  • Opioids
  • Public Assistance
  • Fiscal Note

Read the bill at the source

This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.

Work in government? Get Civic IQ free →

Start finding government buyers today.
It's free.

B2G and SLED sales intelligence. Surface government procurement signals from 100,000+ state, local, and education agencies months before the RFP.

Get started free

No credit card required